LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.44 | 771.67 | 3875 | 8530 | 0.4543 | 0.5928 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.66 | 771.67 | 3727 | 8978 | 0.4151 | 0.5602 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.66 | 771.67 | 4797 | 8978 | 0.5343 | 0.6755 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 62.66 | 771.67 | 4069 | 8978 | 0.4532 | 0.5994 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.88 | 771.67 | 3906 | 9447 | 0.4135 | 0.5664 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.88 | 771.67 | 5041 | 9447 | 0.5336 | 0.6809 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.88 | 771.67 | 4209 | 9447 | 0.4455 | 0.5991 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.10 | 771.67 | 4082 | 9800 | 0.4165 | 0.5751 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.10 | 771.67 | 5285 | 9800 | 0.5393 | 0.6900 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.10 | 771.67 | 4352 | 9800 | 0.4441 | 0.6028 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.32 | 771.67 | 4218 | 10212 | 0.4130 | 0.5775 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.32 | 771.67 | 5566 | 10212 | 0.5450 | 0.6994 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.32 | 771.67 | 4420 | 10212 | 0.4328 | 0.5974 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.54 | 771.67 | 4325 | 10532 | 0.4106 | 0.5795 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.54 | 771.67 | 5766 | 10532 | 0.5474 | 0.7047 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.54 | 771.67 | 4507 | 10532 | 0.4279 | 0.5968 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.76 | 771.67 | 4469 | 10851 | 0.4118 | 0.5849 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.76 | 771.67 | 6018 | 10851 | 0.5546 | 0.7135 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.76 | 771.67 | 4582 | 10851 | 0.4222 | 0.5953 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.02 | 771.67 | 4609 | 11106 | 0.4150 | 0.5913 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.02 | 771.67 | 6321 | 11106 | 0.5691 | 0.7274 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.02 | 771.67 | 4671 | 11106 | 0.4206 | 0.5968 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.25 | 771.67 | 4721 | 11367 | 0.4153 | 0.5947 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.25 | 771.67 | 6590 | 11367 | 0.5797 | 0.7379 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.25 | 771.67 | 4692 | 11367 | 0.4128 | 0.5922 | MN20160304_L01 | L08 |